Latest News about Teva
Recent news which mentions Teva
Neurocrine Biosciences Reports Mixed Q4
February 07, 2025
From Motley Fool
NVIDIA, Teva Pharmaceutical And UPS Are Among Top Large Cap Losers Last Week (Jan 27-Jan 31): Are The Others In Your Portfolio?
February 02, 2025
From Benzinga
What Analysts Are Saying About Teva Pharmaceutical Indus Stock
January 30, 2025
Tickers
TEVA
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 29, 2025
From Benzinga
Tickers
TEVA
From Motley Fool
Crude Oil Down 1.5%; Teva Pharmaceutical Shares Plummet
January 29, 2025
From Benzinga
Stocks Tick Down Ahead Of Fed Meeting, Nvidia Jitters Resume, Trump Media Rallies: What's Driving Markets Wednesday?
January 29, 2025
From Benzinga
Nasdaq Down Over 100 Points; Corning Posts Upbeat Earnings
January 29, 2025
From Benzinga
Teva Pharmaceutical Stock Falls On Q4 Earnings: What's Going On?
January 29, 2025
From Benzinga
Manhattan Associates, LendingClub And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
January 29, 2025
From Benzinga
Earnings Scheduled For January 29, 2025
January 29, 2025
From Benzinga
Teva's Duvakitug Set To Shake Up IBD Treatment, Analyst Highlights Competitive Data
January 28, 2025
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 27, 2025
From Benzinga
From Benzinga
Peering Into Teva Pharmaceutical Indus's Recent Short Interest
January 27, 2025
Tickers
TEVA
From Benzinga
From Benzinga
Teva Challenges Drug Price Law's Impact On Innovation, Generics
January 17, 2025
From Benzinga
Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
January 17, 2025
From Benzinga
From Benzinga
From Benzinga
CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
January 06, 2025
From Benzinga
Novo Nordisk Pushes FDA To Exclude Compounding For Its Early-Generation Diabetes Drug
January 06, 2025
From Benzinga
Tesla, Avinger, Jet.Ai, Teva, And Netflix: Why These 5 Stocks Are On Investors' Radars Ahead Of Christmas
December 24, 2024
From Benzinga
Stanley Druckenmiller Dumps Street's Hottest AI Stocks — Here's What The Billionaire Investor Is Betting On Next
December 24, 2024
From Benzinga
Billionaire Stanley Druckenmiller Is Selling Nvidia and Palantir and Piling Into One of Wall Street's Hottest Drug Stocks Ahead of 2025
December 24, 2024
From Motley Fool
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
December 22, 2024
From Benzinga
Teva Pharmaceutical, Li Auto, And Darden Restaurants Are Among Top Large Cap Gainers Last Week (December 16-20): Are The Others In Your Portfolio?
December 22, 2024
From Benzinga
My Top 10 Portfolio Holdings for 2025
December 20, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.